EMMA Healthcare is a specialized company developing AI-based digital healthcare solutions and medical devices. It offers smart cradles utilizing non-contact biosignal analysis technology, plasma aesthetic devices, and hospital medical equipment, focusing on research into innovative technologies to improve the quality of human life.EMMAHealthcareisaspecializedcompanydevelopingAI-baseddigitalhealthcaresolutionsandmedicaldevices.Itofferssmartcradlesutilizingnon-contactbiosignalanalysistechnology,plasmaaestheticdevices,andhospitalmedicalequipment,focusingonresearchintoinnovativetechnologiestoimprovethequalityofhumanlife.
Key Products/TechnologiesKeyProducts/Technologies
InterLucy: An advanced laser device for non-invasive fat reduction in hospitals, with domestic KFDA Class 3 medical device product approval.InterLucy:Anadvancedlaserdevicefornon-invasivefatreductioninhospitals,withdomesticKFDAClass3medicaldeviceproductapproval.
PlaLucy: A new concept homecare wellness device integrating soft bio cold plasma, galvanic, and vibration functions, holding European CE and US FDA certifications.PlaLucy:Anewconcepthomecarewellnessdeviceintegratingsoftbiocoldplasma,galvanic,andvibrationfunctions,holdingEuropeanCEandUSFDAcertifications.
Bebelucy: An AI-based IoT smart baby crib, providing real-time non-contact monitoring of infant vital signs such as body temperature, heart rate, and surrounding environmental information (temperature, humidity, air quality). Features include AI voice recognition for detecting baby cries and automatic bouncing mode activation, with domestic KC certification and child product safety confirmation completed.Bebelucy:AnAI-basedIoTsmartbabycrib,providingreal-timenon-contactmonitoringofinfantvitalsignssuchasbodytemperature,heartrate,andsurroundingenvironmentalinformation(temperature,humidity,airquality).FeaturesincludeAIvoicerecognitionfordetectingbabycriesandautomaticbouncingmodeactivation,withdomesticKCcertificationandchildproductsafetyconfirmationcompleted.
Sterlucy: A hospital-use high-speed sterilizer incorporating IoT-linked cold plasma technology.Sterlucy:Ahospital-usehigh-speedsterilizerincorporatingIoT-linkedcoldplasmatechnology.
Smart Recliner: An AI healthcare-enabled smart recliner, currently under joint development with Jacomo, a leading domestic sofa manufacturer.SmartRecliner:AnAIhealthcare-enabledsmartrecliner,currentlyunderjointdevelopmentwithJacomo,aleadingdomesticsofamanufacturer.
Emma AI: A proprietary AI engine that comprehensively analyzes multimodal data including camera images, voice, and brainwaves to precisely measure user heart rate, stress, and emotional states non-contact.EmmaAI:AproprietaryAIenginethatcomprehensivelyanalyzesmultimodaldataincludingcameraimages,voice,andbrainwavestopreciselymeasureuserheartrate,stress,andemotionalstatesnon-contact.
Lucycare: Technology under development through a joint R&D project with a Canadian company, focusing on biosignal (rPPG, EEG) measurement, emotion analysis based on facial expressions, and advanced models for assessing mental health and dementia risk in the elderly.Lucycare:TechnologyunderdevelopmentthroughajointR&DprojectwithaCanadiancompany,focusingonbiosignal(rPPG,EEG)measurement,emotionanalysisbasedonfacialexpressions,andadvancedmodelsforassessingmentalhealthanddementiariskintheelderly.
Core AdvantagesCoreAdvantages
Innovative AI and Plasma Technology: A leading company in AI-based non-contact biosignal analysis technology and its proprietary multimodal AI engine 'Emma AI'. Possesses capabilities in developing aesthetic and medical devices through cold plasma application technology.InnovativeAIandPlasmaTechnology:AleadingcompanyinAI-basednon-contactbiosignalanalysistechnologyanditsproprietarymultimodalAIengine'EmmaAI'.Possessescapabilitiesindevelopingaestheticandmedicaldevicesthroughcoldplasmaapplicationtechnology.
Global Market Competitiveness and Awards: A remarkable achievement of winning the CES Innovation Award for three consecutive years from 2022 at the world's largest electronics exhibition. Selected for the 'Global Hidden Champion 1000+ Project' by the Ministry of SMEs and Startups in 2025.GlobalMarketCompetitivenessandAwards:AremarkableachievementofwinningtheCESInnovationAwardforthreeconsecutiveyearsfrom2022attheworld'slargestelectronicsexhibition.Selectedforthe'GlobalHiddenChampion1000+Project'bytheMinistryofSMEsandStartupsin2025.
Securing Numerous Patents and Certifications: A technology-driven company holding 18 patents as of November 2025, including 2 domestic patent registrations and 2 US patent applications completed for Bebelucy. InterLucy holds domestic KFDA Class 3 medical device product approval, PlaLucy has European CE and US FDA certifications, and Bebelucy has domestic KC certification and child product safety confirmation.SecuringNumerousPatentsandCertifications:Atechnology-drivencompanyholding18patentsasofNovember2025,including2domesticpatentregistrationsand2USpatentapplicationscompletedforBebelucy.InterLucyholdsdomesticKFDAClass3medicaldeviceproductapproval,PlaLucyhasEuropeanCEandUSFDAcertifications,andBebelucyhasdomesticKCcertificationandchildproductsafetyconfirmation.
Active R&D and Government Project Execution: Continuous technological advancement through various national R&D projects funded by the Ministry of Science and ICT, Ministry of Trade, Industry and Energy, and international joint research with partners in the UK and Canada.ActiveR&DandGovernmentProjectExecution:ContinuoustechnologicaladvancementthroughvariousnationalR&DprojectsfundedbytheMinistryofScienceandICT,MinistryofTrade,IndustryandEnergy,andinternationaljointresearchwithpartnersintheUKandCanada.
B2B and B2C Market Scalability: A business model expanding into B2B technology licensing and SaaS models for partners in various industries such as telemedicine, digital therapeutics, and smart homes, by providing its AI engine 'Emma AI' as an API.B2BandB2CMarketScalability:AbusinessmodelexpandingintoB2BtechnologylicensingandSaaSmodelsforpartnersinvariousindustriessuchastelemedicine,digitaltherapeutics,andsmarthomes,byprovidingitsAIengine'EmmaAI'asanAPI.
Target IndustrieTargetIndustrie
Medical institutions and hospitals (non-invasive fat reduction devices, high-speed sterilizers).Medicalinstitutionsandhospitals(non-invasivefatreductiondevices,high-speedsterilizers).
Infant health management and childcare industry (AI smart baby cribs).Infanthealthmanagementandchildcareindustry(AIsmartbabycribs).
Aesthetic and wellness industry (plasma homecare devices).Aestheticandwellnessindustry(plasmahomecaredevices).
Smart home and furniture industry (AI healthcare-enabled smart recliners).Smarthomeandfurnitureindustry(AIhealthcare-enabledsmartrecliners).
Senior care and chronic disease management (multimodal AI care systems, dementia diagnosis technology development).Seniorcareandchronicdiseasemanagement(multimodalAIcaresystems,dementiadiagnosistechnologydevelopment).
Digital healthcare platforms and solutions (telemedicine, digital therapeutics, education, etc.).Digitalhealthcareplatformsandsolutions(telemedicine,digitaltherapeutics,education,etc.).
Major MarketsMajorMarkets
China, Hong Kong, VietnamChina,HongKong,Vietnam
United KingdomUnitedKingdom
United States, CanadaUnitedStates,Canada
Certifications/PatentsCertifications/Patents
Domestic KFDA Class 3 medical device product approval (InterLucy).DomesticKFDAClass3medicaldeviceproductapproval(InterLucy).
European CE certification (PlaLucy).EuropeanCEcertification(PlaLucy).
US FDA certification (PlaLucy).USFDAcertification(PlaLucy).
Domestic KC certification and child product safety confirmation (Bebelucy).DomesticKCcertificationandchildproductsafetyconfirmation(Bebelucy).
Bebelucy trademark officially registered in the US (August 2022).BebelucytrademarkofficiallyregisteredintheUS(August2022).
2 domestic patent registrations and 1 application (related to Bebelucy).2domesticpatentregistrationsand1application(relatedtoBebelucy).
2 US patent applications completed (related to Bebelucy).2USpatentapplicationscompleted(relatedtoBebelucy).
Possession of a total of 18 patents (as of November 2025).Possessionofatotalof18patents(asofNovember2025).